HHS Price Negotiations Could Be Delayed When Biologics Have Biosimilars Pending Under Bill

 
• By Cathy Kelly
  
Resurrected Drug Pricing Bill May Have Path To Passage • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access